Promoter and Public shareholding changes are minimal, indicating stability; however, they align with sector averages showing no change.

Institutional shareholding has increased both YoY (1.99%) and QoQ (1.16%), indicating confidence in Marksans Pharma compared to the sector, which saw no changes.

Despite positive institutional movement, the lack of significant changes among Promoters and the Public suggests a cautious sentiment in the broader market.